| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,295 |
8,869 |
$555K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,733 |
1,992 |
$207K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,552 |
5,922 |
$116K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,488 |
1,946 |
$101K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
669 |
463 |
$95K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,396 |
2,764 |
$89K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
942 |
852 |
$78K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
701 |
655 |
$52K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,970 |
1,653 |
$46K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
539 |
352 |
$42K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
524 |
444 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
697 |
627 |
$31K |
| 96160 |
|
1,261 |
1,127 |
$18K |
| 90686 |
|
1,415 |
1,129 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
325 |
288 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
104 |
80 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
347 |
278 |
$4K |
| 90734 |
|
256 |
211 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
56 |
49 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
235 |
199 |
$4K |
| 99051 |
|
1,118 |
572 |
$4K |
| 90651 |
|
255 |
219 |
$4K |
| 83655 |
|
267 |
229 |
$3K |
| 90620 |
|
122 |
109 |
$2K |
| 90661 |
|
101 |
99 |
$2K |
| 87631 |
|
13 |
13 |
$1K |
| 94762 |
|
885 |
619 |
$1K |
| 36416 |
|
284 |
250 |
$1K |
| 90715 |
|
71 |
56 |
$931.77 |
| 90716 |
|
67 |
58 |
$903.06 |
| 90707 |
|
66 |
57 |
$886.35 |
| 85018 |
|
291 |
253 |
$675.12 |
| 90688 |
|
78 |
65 |
$534.88 |
| 0003A |
|
12 |
12 |
$505.68 |
| 90670 |
|
43 |
40 |
$503.66 |
| 86580 |
|
102 |
82 |
$429.96 |
| 90648 |
|
62 |
51 |
$396.80 |
| 90633 |
|
16 |
13 |
$263.21 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,793 |
3,160 |
$25.65 |
| 90461 |
|
1,724 |
1,334 |
$0.00 |
| 1160F |
|
13,442 |
10,556 |
$0.00 |
| 4274F |
|
1,043 |
860 |
$0.00 |
| 3078F |
|
1,862 |
1,646 |
$0.00 |
| 4124F |
|
126 |
122 |
$0.00 |
| 1159F |
|
13,429 |
10,547 |
$0.00 |
| 1003F |
|
1,004 |
904 |
$0.00 |
| 4120F |
|
364 |
349 |
$0.00 |
| 3210F |
|
376 |
261 |
$0.00 |
| 91300 |
|
24 |
24 |
$0.00 |
| 1036F |
|
918 |
838 |
$0.00 |
| 3074F |
|
1,901 |
1,681 |
$0.00 |
| 1220F |
|
753 |
685 |
$0.00 |
| 4045F |
|
373 |
260 |
$0.00 |